1. Home
  2. PXLW vs VNRX Comparison

PXLW vs VNRX Comparison

Compare PXLW & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

HOLD

Current Price

$6.06

Market Cap

39.1M

Sector

Technology

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.19

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXLW
VNRX
Founded
1997
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
31.9M
IPO Year
2000
2012

Fundamental Metrics

Financial Performance
Metric
PXLW
VNRX
Price
$6.06
$0.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$14.33
$2.50
AVG Volume (30 Days)
25.7K
1.5M
Earning Date
06-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
$693,000.00
$1,233,511.00
Revenue This Year
$5,066.23
$68.22
Revenue Next Year
N/A
$382.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
59.10
52 Week Low
$0.46
$0.17
52 Week High
$15.42
$0.94

Technical Indicators

Market Signals
Indicator
PXLW
VNRX
Relative Strength Index (RSI) 47.96 36.71
Support Level $5.67 $0.17
Resistance Level $6.77 $0.27
Average True Range (ATR) 0.29 0.02
MACD -0.01 0.00
Stochastic Oscillator 39.13 5.36

Price Performance

Historical Comparison
PXLW
VNRX

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: